MFDS — authorised 1 September 2022
- Marketing authorisation holder: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
- Status: likely_approved
🇰🇷 Spevigo in South Korea
MFDS authorised Spevigo on 1 September 2022
Marketing authorisation
Spevigo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Spevigo approved in South Korea?
Yes. MFDS authorised it on 1 September 2022.
Who is the marketing authorisation holder for Spevigo in South Korea?
BOEHRINGER INGELHEIM PHARMACEUTICALS INC holds the South Korean marketing authorisation.